NCT05495568
- Conditions
- Moderate to Severe Chronic Plaque Psoriasis
- Locations
-
- CT-P17 3.3 investigational site Tallinn, Estonia
Clinical trial condition
Moderate to Severe Chronic Plaque Psoriasis
Explore clinical trials studying Moderate to Severe Chronic Plaque Psoriasis. Study availability and eligibility vary by location and protocol.
17 public trials
0 recruiting studies
Moderate to Severe Chronic Plaque Psoriasis trial results
NCT04785326
- Conditions
- Moderate to Severe Chronic Plaque Psoriasis
- Locations
-
- Central Sooner Research Norman, Oklahoma, United States
- Jordan Valley Dermatology Center West Jordan, Utah, United States
NCT02223039
- Conditions
- Moderate to Severe Chronic Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
- Locations
-
- Alliance Dermatology & MOHS Center, PC Phoenix, Arizona, United States
- Northwest AR Clinical Trials Center, PLLC. Rogers, Arkansas, United States
- Renstar Medical Research Ocala, Florida, United States
- Progressive Medical Research Port Orange, Florida, United States
NCT01855880
- Conditions
- Moderate to Severe Chronic Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
- Locations
-
- Baptist Health Certer for Clinical Research Little Rock, Arkansas, United States
- Northwest AR Clinical Trials Rogers, Arkansas, United States
- Visions Clinical Research Boynton Beach, Florida, United States
- Renstar Medical Research Ocala, Florida, United States
Completed
Community Based Trial for AMEVIVE®
NCT00168753
- Conditions
- Moderate to Severe Chronic Plaque Psoriasis
- Locations
-
- Monheit Dermatology Associates Birmingham, Alabama, United States
- Bayshore Dermatology Fairhope, Alabama, United States
- Jayne Fortson Anchorage, Alaska, United States
- Bakersfield Dermatology & Skin Cancer Medical Group Bakersfield, California, United States
NCT00601107
- Conditions
- Moderate to Severe Chronic Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
- Locations
-
- Birmingham, Alabama, United States
- Hot Springs, Arizona, United States
- Little Rock, Arkansas, United States
- Irvine, California, United States
Active, Not Recruiting
Efficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical Trial
NCT06591273
- Conditions
- Moderate to Severe Chronic Plaque Psoriasis
- Locations
-
- Department of Dermatology, Services Institute of Medical Sciences/ Services Hospital Lahore, Punjab Province, Pakistan